Short Interest in SanBio Company Limited (OTCMKTS:SNBIF) Drops By 30.3%

SanBio Company Limited (OTCMKTS:SNBIF) saw a large decrease in short interest in February. As of February 15th, there was short interest totalling 445,400 shares, a decrease of 30.3% from the January 31st total of 639,400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 4,454.0 days.

SanBio Stock Performance

Shares of SNBIF remained flat at C$6.55 during mid-day trading on Wednesday. SanBio has a 12-month low of C$4.65 and a 12-month high of C$6.55. The business has a 50 day moving average price of C$5.22 and a 200-day moving average price of C$4.52.

About SanBio

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.